Livlong 365 OPD healthtech platform to invest Rs. 100 crore in major offline expansion, targets 100 branches by 2027: Our Bureau, Bengaluru Monday, August 18, 2025, 17:15 Hrs [IST ...

Caris Life Sciences demonstrates scientific rigor with clinical validation of US FDA approved MI Cancer Seek: Irving, Texas Monday, August 18, 2025, 16:00 Hrs [IST] Caris Life Sci ...

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

CPTx & NanoCell Therapeutics project receives EU funding for innovative in vivo CAR T therapy with immune-silent single-stranded DNA: Munich, Germany Monday, August 18, 2025, 15:0 ...

US FDA approves Precigen’s Papzimeos for the treatment of adults with recurrent respiratory papillomatosis: Germantown, Maryland Monday, August 18, 2025, 17:00 Hrs [IST] Precige ...

Everest announces etrasimod gets recommendation in ACG Clinical Guideline Update: Ulcerative Colitis in adults for induction and maintenance phase of moderately to severely active UC ...

Galvanize Therapeutics begins patient enrolment in PROPEL Registry evaluating Aliya PEF Ablation for soft tissue lesions: Redwood City, California Monday, August 18, 2025, 12:00 H ...

Zeus Hygia unveils Metaberine green process, enriched berberine powered by proprietary technology: Our Bureau, Bengaluru Monday, August 18, 2025, 13:45 Hrs [IST] Zeus Hygia Lifesc ...

HCGMCC partners with Qure.ai to deploy AI-powered imaging for early lung disease detection: Our Bureau, Mumbai Monday, August 18, 2025, 15:15 Hrs [IST] HCG Manavata Cancer Centre ...

Eight Roads Ventures to host fourth edition of annual healthcare conference, Scale-Up Health on Sept 10, 2025 in Mumbai: Our Bureau, Mumbai Monday, August 18, 2025, 09:00 Hrs [IST ...

Scientists at the National Institutes of Health (NIH) successfully reduced the severity of late-onset Tay-Sachs (LOTS) disease in human cell cultures and a mouse model by using a novel gene-editing ...

US FDA approves Novo Nordisk’s Wegovy to treat metabolic dysfunction-associated steatohepatitis: Bagsværd, Denmark Monday, August 18, 2025, 11:00 Hrs [IST] Novo Nordisk, a lead ...